According to Viveve Medical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.000314093. At the end of 2022 the company had a P/S ratio of 1.06.
Year | P/S ratio | Change |
---|---|---|
2022 | 1.06 | -43.52% |
2021 | 1.88 | 1.26% |
2020 | 1.86 | 182.79% |
2019 | 0.6569 | -63.27% |
2018 | 1.79 | -71.68% |
2017 | 6.32 | -17.76% |
2016 | 7.68 | -28.28% |
2015 | 10.7 | -77.61% |
2014 | 47.8 | 1251.28% |
2013 | 3.54 | -8.12% |
2012 | 3.85 | -16.84% |
2011 | 4.63 | 248.53% |
2010 | 1.33 | 41.01% |
2009 | 0.9425 | 182.85% |
2008 | 0.3332 | -84.28% |
2007 | 2.12 | -16.1% |
2006 | 2.53 | 30.37% |
2005 | 1.94 | -37.23% |
2004 | 3.09 | -25.05% |
2003 | 4.12 | 112.1% |
2002 | 1.94 | 9.94% |
2001 | 1.77 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | 6.49 | 2,066,233.86% | ๐บ๐ธ USA |
Philips PHG | 0.9821 | 312,573.63% | ๐ณ๐ฑ Netherlands |